Skip to content
10-Q

Quarterly Report

Acrivon Therapeutics, Inc. ACRV

0001193125-25-280215

← back to feed
Filed
Nov 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 7, 2025 31.56M sh
Shares Diluted Q3 2025 · Sep 30, 2025 38.56M sh
Shares Diluted Q3 2025 · Sep 30, 2025 38.46M sh
Shares Diluted Q3 2025 · Sep 30, 2024 38.11M sh
Shares Diluted Q3 2025 · Sep 30, 2024 32.3M sh
Capex Q3 2025 · Sep 30, 2025 $1.45M
Capex Q3 2025 · Sep 30, 2024 $1.94M
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$48.43M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$48.31M
Short Term Investments Q3 2025 · Sep 30, 2025 $93.85M
Short Term Investments Q3 2025 · Dec 31, 2024 $139.66M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $35.41M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $39.82M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $43.42M
Stockholders Equity Q3 2025 · Sep 30, 2025 $128.6M
Stockholders Equity Q3 2025 · Jun 30, 2025 $143.04M
Stockholders Equity Q3 2025 · Mar 31, 2025 $160.39M
Stockholders Equity Q3 2025 · Dec 31, 2024 $176.79M
Stockholders Equity Q3 2025 · Sep 30, 2024 $196.89M
Stockholders Equity Q3 2025 · Jun 30, 2024 $216.06M
Stockholders Equity Q3 2025 · Mar 31, 2024 $107.98M
Stockholders Equity Q3 2025 · Dec 31, 2023 $121.2M
Current Liabilities Q3 2025 · Sep 30, 2025 $14.89M
Current Liabilities Q3 2025 · Dec 31, 2024 $17.21M
Total Liabilities Q3 2025 · Sep 30, 2025 $16.7M
Total Liabilities Q3 2025 · Dec 31, 2024 $19.8M
Current Assets Q3 2025 · Sep 30, 2025 $130.36M
Current Assets Q3 2025 · Dec 31, 2024 $181.63M
Total Assets Q3 2025 · Sep 30, 2025 $145.3M
Total Assets Q3 2025 · Dec 31, 2024 $196.59M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.47
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.53
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.59
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.79
Eps Basic Q3 2025 · Sep 30, 2025 −$0.47
Eps Basic Q3 2025 · Sep 30, 2025 −$1.53
Eps Basic Q3 2025 · Sep 30, 2024 −$0.59
Eps Basic Q3 2025 · Sep 30, 2024 −$1.79
Sga Expense Q3 2025 · Sep 30, 2025 $6.04M
Sga Expense Q3 2025 · Sep 30, 2025 $18.75M
Sga Expense Q3 2025 · Sep 30, 2024 $6.28M
Sga Expense Q3 2025 · Sep 30, 2024 $18.88M
Rd Expense Q3 2025 · Sep 30, 2025 $13.65M
Rd Expense Q3 2025 · Sep 30, 2025 $45.24M
Rd Expense Q3 2025 · Sep 30, 2024 $18.86M
Rd Expense Q3 2025 · Sep 30, 2024 $45.36M
Net Income Q3 2025 · Sep 30, 2025 −$18.23M
Net Income Q3 2025 · Sep 30, 2025 −$58.92M
Net Income Q3 2025 · Jun 30, 2025 −$21.01M
Net Income Q3 2025 · Mar 31, 2025 −$19.68M
Net Income Q3 2025 · Sep 30, 2024 −$22.44M
Net Income Q3 2025 · Sep 30, 2024 −$57.73M
Net Income Q3 2025 · Jun 30, 2024 −$18.8M
Net Income Q3 2025 · Mar 31, 2024 −$16.49M
Operating Income Q3 2025 · Sep 30, 2025 −$19.69M
Operating Income Q3 2025 · Sep 30, 2025 −$64M
Operating Income Q3 2025 · Sep 30, 2024 −$25.14M
Operating Income Q3 2025 · Sep 30, 2024 −$64.25M